Antiprion immunotherapy: To suppress or to stimulate?

Nature Reviews Immunology

Volumn 4, Issue 9, 2004, Pages 725-736

  Aguzzi, Adriano ^a   Sigurdson, Christina J ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR5; HYBRID PROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOSTIMULATING AGENT; IMMUNOSUPPRESSIVE AGENT; LYMPHOTOXIN BETA; MYELOID DIFFERENTIATION FACTOR 88; OLIGODEOXYNUCLEOTIDE; PRION PROTEIN; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR 1; VACCINE;

BOVINE SPONGIFORM ENCEPHALOPATHY; CHRONIC WASTING DISEASE; CPG ISLAND; CREUTZFELDT JAKOB DISEASE; DENDRITIC CELL; DISEASE TRANSMISSION; FATAL FAMILIAL INSOMNIA; FELINE SPONGIFORM ENCEPHALOPATHY; GERSTMANN STRAUSSLER SCHEINKER SYNDROME; HUMAN; IMMUNIZATION; IMMUNOPROPHYLAXIS; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; KURU; NONHUMAN; PATHOPHYSIOLOGY; PRION DISEASE; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; REVIEW; SCRAPIE; TRANSMISSIBLE MINK ENCEPHALOPATHY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; LYMPHOID TISSUE; PRION DISEASES; PRPSC PROTEINS;

EID: 4544224048     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri1437     Document Type: Review

References (148)

1. Aguzzi, A. & Haass, C. Games played by rogue proteins in prion disorders and Alzheimer's disease. Science 302, 814-818 (2003).
2. Cuille, J. & Chelle, P. L. Experimental transmission of trembling to the goat. C. R. Hebd. Seances Acad. Sci. D, Sci. Nat. 208, 1058-1160 (1939).
3. Wells, G. A. et al. A novel progressive spongiform encephalopathy in cattle. Vet. Rec. 121, 419-420 (1987).
4. Weissmann, C. & Aguzzi, A. Bovine spongiform encephalopathy and early onset variant Creutzfeldt-Jakob disease. Curr. Opin. Neurobiol. 7, 695-700 (1997).
5. Taylor, D. M. Inactivation of transmissible degenerative encephalopathy agents: a review. Vet. J. 159, 10-17 (2000).
6. Aguzzi, A. Neuro-immune connection in spread of prions in the body? Lancet 349, 742-743 (1997).
7. Nicotera, P. A route for prion neuroinvasion. Neuron 31, 345-348 (2001).
8. Sc, in a hamster infected with scrapie.
9. Stahl, N., Borchett, D. R., Hsiao, K. & Prusiner, S. B. Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell 51, 229-240 (1987).
10. Moudjou, M., Frobert, Y., Grassi, J. & La Bonnardiere, C. Cellular prion protein status in sheep: tissue-specific biochemical signatures. J. Gen. Virol. 82, 2017-2024 (2001).
11. Miele, G. et al. Embryonic activation and developmental expression of the murine prion protein gene. Gene Expr. 11, 1-12 (2003).
12. Büeler, H. R. et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356, 577-582 (1992).
13. Collinge, J. et al. Prion protein is necessary for normal synaptic function. Nature 370, 295-297 (1994).
14. Tobler, I. et al. Altered arcadian activity rhythms and sleep in mice devoid of prion protein. Nature 380, 639-642 (1996).
15. Glockshuber, R. et al. Prion protein structural features indicate possible relations to signal peptidases. FEBS Lett. 426, 291-296 (1998).
16. Brown, D. R., Schulz-Schaeffer, W. J., Schmidt, B. & Kretzschmar, H. A. Prion protein-deficient cells show altered response to oxidative stress due to decreased SOD-1 activity. Exp. Neurol. 146, 104-112 (1997).
17. Brown, D. R. et al. Normal prion protein has an activity like that of superoxide dismutase. Biochem. J. 344, 1-5 (1999).
18. Sakudo, A. et al. Impairment of Superoxide dismutase actuation by N-terminally truncated prion protein (PrP) in PrP-deficient neuronal cell line. Biochem. Biophys. Res. Commun. 308, 660-667 (2003).
19. Waggoner, D. J. et al. Brain copper content and cuproenzyme activity do not vary with prion protein expression level. J. Biol. Chem. 275, 7455-7458 (2000).
20. Hutter, G., Heppner, F. L. & Aguzzi, A. No Superoxide dismutase activity of cellular prion protein in vivo. Biol. Chem. 384, 1279-1285 (2003).
21. Prusiner, S. B. Novel proteinaceous infectious particles cause scrapie. Science 216, 136-144 (1982). Classic enunciation of the protein-only hypothesis of prion disease by Stanley Prusiner.
22. Sc molecules with different conformations Nature Med. 4, 1157-1165 (1998).
23. Aguzzi, A. & Heikenwalder, M. Prion diseases: cannibals and garbage piles. Nature 423, 127-129 (2003).
24. c.
25. Weissmann, C. Spongrform encephalopathies. The prion's progress. Natures 349, 569-571 (1991).
26. Telling, G. C. et al. Prion propagation in mice expressing human and chimeric PrP transgenes implicates the interaction of cellular PrP with another protein. Cell 83, 79-90 (1995).
27. Weissmann, C. A 'unified theory' of prion propagation. Nature 352, 679-683 (1991).
28. Deleault N. R., Lucassen, R. W. & Supattapone, S. RNA molecules stimulate prion protein conversion. Nature 425, 717-720 (2003).
29. Aguzzi, A. & Weissmann, C. Prion research: the next frontiers. Nature 389, 795-798 (1997).
30. Sc in vivo and antagonizes prion disease. Cell 113, 49-60 (2003).
31. Aguzzi, A. & Polymenuou, M. Mammalian prion biology. One century of evolving concepts. Cell 116, 313-327 (2004).
32. McKinley, M. P., Bolton, D, C. & Prusiner, S. B. Aprotease-resistant protein is a structural component of the scrapie prion. Cell 35, 57-62 (1983).
33. Kayed, R. et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300, 486-489 (2003).
34. Raeber, A. J. et al. Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie. EMBO J. 16, 6057-6065 (1997).
35. Mallucci, G. et al. Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302, 871-874 (2003). Shows that depletion of PrP from the neurons of transgenlc mice prevents the development of prion disease in infected mice.
36. Basler, K. et al. Scrapie and cellular PrP isoforms are encoded by the same chromosomal gene. Cell 46, 417-428 (1986).
37. Büeler, H. R. et al. Mice devoid of PrP are resistant to scrapie. Cell 73, 1339-1347 (1993). Shows that PrP is required for susceptibility to prion infections. An important milestone in prion research.
38. Brandner, S. et al. Normal host prion protein necessary for scrapie-induced neurotoxicity. Nature 379, 339-343 (1996).
39. Sc levels but delayed onset of disease in scrapie-inoculated mice heterozygous for a disrupted PrP gene. Mol. Med. 1, 19-30 (1994).
40. Manson, J. C., Clarke, A. R., McBride, P. A., McConnell, I. & Hope, J. PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration 3, 331-340 (1994).
41. Hilton, D. A. et al. Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J. Clin. Pathol. 57, 300-302 (2004).
42. Heggebo, R., Press, C. M., Gunnes, G., Gonzalez, L. & Jeffrey, M. Distribution and accumulation of PrP in gut-associated and peripheral lymphoid tissue of scrapie-affected Suffolk sheep. J. Gen. Virol. 83, 479-489 (2002).
43. Jeffrey, M., McGovern, G., Martin, S., Goodsir, C. M. & Brown, K. L. Cellular and sub-cellular localisation of PrP in the lymphoreticular system of mice and sheep. Arch. Virol. Suppl. 16, 23-38 (2000).
44. res in mule deer fawns (Odocoileus hemionus). J. Gen. Virol. 80, 2757-2764 (1999).
45. Terry, L. A. et al. Detection of disease-specific PrP in the distal ileum of cattle exposed orally to the agent of bovine spongiform encephalopathy. Vet. Rec. 152, 387-392 (2003).
46. Wells, G. A. et al. Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update. Vet. Rec. 142, 103-106 (1998).
47. Glatzel, M., Abela, E., Maissen, M. & Aguzzi, A. Extraneural pathologic prion protein in sporadic Creutzfeldt-Jakob disease. N. Engl. J. Med. 349, 1812-1820 (2003).
48. Houston, E. F., Halliday, S. I., Jeffrey, M., Goldmann, W. & Hunter, N. New Zealand sheep with scrapie-susceptible PrP genotypes succumb to experimental challenge with a sheep-passaged scrapie isolate (SSBP/1). J. Gen. Virol. 83, 1247-1250 (2002).
49. Fraser, H. & Dickinson, A. G. Pathogenesis of scrapie in the mouse: the role of the spleen. Nature 226, 462-163 (1970). Shows that PrP accumulates in lymphoid organs in the mouse model of scrapie.
50. Heppner, F. L., Prinz, M. & Aguzzi, A. Pathogenesis of prion diseases: possible implications of microglial cells. Prog. Brain Res. 132, 737-750 (2001).
51. Betmouni, S., Perry, V. H. & Gordon, J. L. Evidence for an early inflammatory response in the central nervous system of mice with scrapie. Neuroscience 74, 1-5 (1996).
52. Perry, V. H., Cunningham, C. & Boche, D. Atypical inflammation in the central nervous system in prion disease. Curr. Opin. Neurol. 15, 349-354 (2002).
53. Klein, M. A. et al. A crucial role for B cells in neuroinvasive scrapie. Nature 390, 687-690 (1997).
54. Klein, M. A. et al. Complement facilitates early prion pathogenesis. Nature Med. 7, 488-492 (2001).
55. Prinz, M. et al. Prion pathogenesis in the absence of Toll-like receptor signalling. EMBO Rep. 4, 195-199 (2003).
56. Prinz, M. et al. Positioning of follicular dendritic cells within the spleen controls prion neuroinvasion. Nature 425, 957-962 (2003).
57. Aguzzi, A. Prions and the immune system: a journey through gut, spleen, and nerves. Adv. Immunol. 81, 123-171 (2003).
58. Griffith, J. S. Self-repllcation and scrapie. Nature 215, 1043-1044 (1967). A mathematician proposes that the scrapie agent might not be a traditional infectious agent but, instead, an infectious protein.
59. Pattison, I. H. & Millson, G. C. Further observations on the experimental production of scrapie in goats and sheep. J. Comp. Pathol. 70, 182-193 (1960).
60. Pattison, I. H. & Millson, G. C. Distribution of the scrapie agent in the tissues of experimentally inoculated goats. J. Comp. Pathol. 72, 233-244 (1962).
61. Heppner, F. L. et al. Transepithelial prion transport by M cells. Nature Med. 7, 976-977 (2001).
62. Prinz, M. et al. Oral prion infection requires normal numbers of Peyer's patches but not of enteric lymphocytes. Am. J. Pathol. 162, 1103-1111 (2003).
63. Sc in lymphoid tissues of lambs experimentally exposed to the scrapie agent. J. Comp. Pathol. 128, 172-181 (2003).
64. Sc from the gut. J. Gen. Virol. 83, 267-271 (2002).
65. Aucouturier, P. et al. Infected splenic dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie. J. Clin. Invest. 108, 703-708 (2001).
66. Prinz, M. et al. Lymph nodal prion replication and neuroinvasion in mice devoid of follicular dendritic cells. Proc. Natl Acad. Sci. USA 99, 919-924 (2002).
67. Montrasio, F. et al. Impaired prion replication in spleens of mice lacking functional follicular dendritic cells. Science 288, 1257-1259 (2000).
68. Mabbott, N. A., Young, J., McConnell, I. & Bruce, M. E. Follicuiar dendritic cell dedifferentiation by treatment with an inhibitor of the lymphotoxin pathway dramatically reduces scrapie susceptibility. J. Virol. 77, 6845-6854 (2003).
69. Mabbott, N. A., Mackay, F., Minns, F. & Bruce, M. E. Temporary inactivation of follicular dendritic cells delays neuroinvasion of scrapie. Nature Med. 6, 719-720 (2000).
70. c is required for prions to reach the CNS after a peripheral exposure (either intraperitoneal or intravenous).
71. c in stromal and hematopoietic cells. J. Virol. 75, 7097-7106 (2001).
72. Klein, M. A. et al. PrP expression in B lymphocytes is not required for prion neuroinvasion. Nature Med. 4, 1429-1433 (1998).
73. Brown, K. L. et al. Scrapie replication in lymphoid tissues depends on prion protein-expressing follicular dendritic cells. Nature Med. 5, 1308-1312 (1999).
74. Forster, R. et al. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87, 1037-1047 (1996).
75. Beekes, M., Baldauf, E. & Diringer, H. Sequential appearance and accumulation of pathognomonic markers in the central nervous system of hamsters orally infected with scrapie. J. Gen. Virol. 77, 1925-1934 (1996).
76. Beekes, M., McBride, P. A. & Baldauf, E. Cerebral targeting indicates vagal spread of infection in hamsters fed with scrapie. J. Gen. Virol. 79, 601-607 (1998).
77. Glatzel, M., Heppner, F. L., Albers, K. M. & Aguzzi, A. Sympathetic innervation of lymphoreticular organs is rate limiting for prion neuroinvasion. Neuron 31, 25-34 (2001).
78. Caughey, B. & Race, R. E. Potent inhibition of scrapie-associated PrP accumulation by Congo red. J. Neurochem. 59, 768-771 (1992).
79. Pocchiari, M., Schmittinger, S. & Masullo, C. Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters. J. Gen. Virol. 68, 219-223 (1987).
80. Tagliavini, F. et al. Effectiveness of anthracycline against experimental prion disease in Syrian hamsters. Science 276, 1119-1122 (1997).
81. Caughey, B. & Raymond, G. J. Sulfated polyanion inhibition of scrapte-associated PrP accumulation in cultured cells. J. Virol. 67, 643-650 (1993).
82. Farquhar, C., Dickinson, A. & Bruce, M. Prophylactic potential of pentosan polysulphate in transmissible spongiform encephalopathies. Lancet 353, 117 (1999).
83. Priola, S. A., Raines, A. & Caughey, W. S. Porphyrin and phthalocyanine antiscrapie compounds. Science 287, 1503-1506 (2000).
84. Supattapone, S. et al. Branched polyamines cure prion-infected neuroblastoma cells. J. Virol. 75, 3453-3461 (2001).
85. Soto, C. et al. Reversion of prion protein conformational changes by synthetic β-sheet breaker peptides. Lancet 355, 192-197 (2000).
86. Fraser, H. et al. Replication of scrapie in spleens of SCID mice follows reconstitution with wild-type mouse bone marrow. J. Gen. Virol. 77, 1935-1940 (1996).
87. Jeffrey, M., McGovern, G., Goodsir, C. M., Brown, K. L. & Bruce, M. E. Sites of prion protein accumulation in scrapie-infected mouse spleen revealed by immuno-electron microscopy. J. Pathol. 191, 323-332 (2000).
88. CWD lymphoid cell targets in early and advanced chronic wasting disease of mule deer. J. Gen. Virol. 83, 2617-2628 (2002).
89. Kitamoto, T., Muramoto, T., Mohri, S., Doh-ura, K. & Tateishi, J. Abnormal isoform of prion protein accumulates in follicular dendritic cells in mice with Creutzfeldt-Jakob disease. J. Virol. 65, 6292-6295 (1991).
90. Mackay, F. & Browning, J. L. Turning off follicular dendritic cells. Nature 395, 26-27 (1998).
91. Wu, Q. et al. The requirement of membrane lymphotoxin for the presence of dendritic cells in lymphoid tissues. J. Exp. Med. 190, 629-638 (1999).
92. Adachi, O. et al. Targeted disruption of the MyD88 gene results in loss of IL-1 - and IL-18-mediated function. Immunity 9, 143-150 (1998).
93. Hemmi, H. et al. A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745 (2000).
94. Sethi, S., Lipford, G., Wagner, H. & Kretzschmar, H. Postexposure prophylaxis against prion disease with a stimulator of innate immunity. Lancet 360, 229-230 (2002).
95. Heikenwalder, M. et al. Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nature Med. 10, 187-192 (2004).
96. Beringue, V. et al. Role of spleen macrophages in the clearance of scrapie agent early in pathogenesis. J. Pathol. 190, 495-502 (2000).
97. Mattel, V. et al. Prion protein is a component of the multimolecular signaling complex involved in T cell activation. FEBS Lett. 560, 14-18 (2004).
98. Manson, J. et al. The prion protein gene: a role in mouse embryogenesis? Development 115, 117-122 (1992).
99. Cashman, N. R. et al. Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell 61, 185-192 (1990).
100. Heppner, F. L. et al. Prevention of scrapie pathogenesis by transgenic expression of anti-prion protein antibodies. Science 294, 178-182 (2001).
101. Enari, M., Flechsig, E. & Weissmann, C. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody. Proc. Natl Acad. Sci. USA 98, 9295-9299 (2001).
102. Peretz, D. et al. Antibodies inhibit prion propagation and clear cell cultures of prion infectivity. Nature 412, 739-743 (2001).
103. White, A. R. et al. Monoclonal antibodies inhibit prion replication and delay the development of prion disease. Nature 422, 80-83 (2003).
104. Solforosi, L. et al. Cross-linking cellular prion protein triggers neuronal apoptosis in vivo. Science 303, 514-516 (2004).
105. Gommerman, J. L. et al. Manipulation of lymphoid microenvironments in nonhuman primates by an inhibitor of the lymphotoxin pathway. J. Clin. Invest. 110, 1359-1369 (2002).
106. Perrier, V et al. Dominant-negative inhibition of prion replication in transgenic mice. Proc. Natl Acad. Sci. USA 99, 13079-13084 (2002).
107. c) is required for scrapie spread within the central nervous system. Proc. Natl Acad. Sci. USA 93, 13148-13151 (1996).
108. Prusiner, S. B. et al. Ablation of the prion protein (PrP) gene in mice prevents scrapie and facilitates production of anti-PrP antibodies. Proc. Natl Acad. Sci. USA 90, 10608-10612 (1993).
109. Koller, M. F., Grau, T. & Christen, P. Induction of antibodies against murine full-length prion protein in wild-type mice. J. Neuroimmunol. 132, 113-116 (2002).
110. Aguzzi, A. & Glatzel, M. vCJD tissue distribution and transmission by transfusion - a worst-case scenario coming true? Lancet 363, 411-412 (2004).
111. Llewelyn, C. A. et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363, 417-421 (2004).
112. Aguzzi, A., Glatzel, M., Montrasio, F., Prinz, M. & Heppner, F. L. Interventional strategies against prion diseases. Nature Rev. Neurosci. 2, 745-749 (2001).
113. Will, R. G. et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347, 921-925 (1996).
114. Chazot, G. et al. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet 347, 1181 (1996).
115. Aguzzi, A. & Weissmann, C. Spongiform encephalopathies: a suspicious signature. Nature 383, 666-667 (1996).
116. Hill, A. F., Zeidler, M., Ironside, J. & Collinge, J. Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 349, 99-100 (1997).
117. Frigg, R., Klein, M. A., Hegyi, I., Zinkernagel, R. M. & Aguzzi, A. Scrapie pathogenesis in subclinically infected B-cell-deficient mice. J. Virol. 73, 9584-9588 (1999).
118. Houston, F., Foster, J. D., Chong, A., Hunter, N. & Bostock, C. J. Transmission of BSE by blood transfusion in sheep. Lancet 356, 999-1000 (2000). Shows that BSE prion infectivity circulates in the blood and is transmissible by transfusion. It was subsequently reported (reference 111) that a probable case of vCJD was contracted through blood transfusion.
119. Hunter, N. et al. Transmission of prion diseases by blood transfusion. J. Gen. Virol. 83, 2897-2905 (2002).
120. Glatzel, M. et al. Human prion diseases: epidemiology and integrated risk assessment. Lancet Neurol. 2, 757-763 (2003).
121. Aguzzi, A., Montrasio, F. & Kaeser, P. S. Prions: health scare and biological challenge. Nature Rev. Mol. Cell Biol. 2, 118-126 (2001).
122. Hadlow, W. J., Kennedy, R. C., Race, R. E. & Eklund, C. M. Virologic and neurohistologic findings in dairy goats affected with natural scrapie. Vet. Pathol. 17, 187-199 (1980).
123. Hadlow, W. J. et al. Course of experimentai scrapie virus infection in the goat. J. Infect. Dis. 129, 559-567 (1974).
124. Buyukmihci, N., Rorvik, M. & Marsh, R. F. Replication of the scrapie agent in ocular neural tissues. Proc. Natl Acad. Sci. USA 77, 1169-1171 (1980).
125. Pattison, I. H., Hoare, M. N., Jebbett, J. N. & Watson, W. A. Spread of scrapie to sheep and goats by oral dosing with foetal membranes from scrapie-affected sheep. Vet. Rec. 90, 465-468 (1972).
126. Endres, R. et al. Mature follicular dendritic cell networks depend on expression of lymphotoxin-β receptor by radioresistant stromal cells and of lymphotoxin-β and tumor necrosis factor by B cells. J. Exp. Med. 189, 159-168 (1999).
127. Gibbs, C. J. Jr, Amyx, H. L. Bacote, A., Masters, C. L. & Gajdusek, D. C. Oral transmission of kuru, Creutzfeldt-Jakob disease, and scrapie to nonhuman primates. J. Infect. Dis. 142, 205-208 (1980).
128. Gibbs, C. J. Jr & Gajdusek, D. C. Infection as the etiology of spongiform encephalopatny (Creutzfeldt-Jakob disease). Soence 165, 1023-1025 (1969).
129. Liberski, P. P. & Mon, S. The Echigo-1 : a panencephalopathic strain of Creutzfeldt-Jakob disease: a passage to hamsters and ultrastructural studies. Folia Neuropathol. 35, 250-254 (1997).
130. Taguchi, Y., Mohri, S., Ironside, J. W., Muramoto, T. & Kitamoto, T. Humanized knock-in mice expressing chimeric prion protein showed varied susceptibility to different human prions. Am. J. Pathol. 163, 2585-2593 (2003).
131. Tateishi, J. Transmission of human prion diseases to rodents. Semin. Virol. 7, 175-180 (1996).
132. Asante, E. A. et al. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J. 21, 6358-6366 (2002).
133. Brown, D. A., Bruce, M. E. & Fraser, J. R. Comparison of the neuropathological characteristics of bovine spongiform encephalopathy (BSE) and variant Creutzfeldt-Jakob disease (vCJD) in mice. Neuropathol. Appl. Neurobiol. 29, 262-272 (2003).
134. Gajdusek, D. C., Gibbs, C. J. Jr & Alpers, M. Transmission and passage of experimenal 'kuru' to chimpanzees. Science 155, 212-214 (1967). Shows that a human TSE, kuru, is transmissible to chimpanzees. Kuru was endemic in the Fore people of Papua New Guinea and transmitted between individuals through ritualistic cannibalism of the dead.
135. Tateishi, J. et al. First experimental transmission of fatal familial insomnia. Nature 376, 434-435 (1995).
136. Tateishi, J., Sato, Y., Nagara, H. & Boellaard, J. W. Experimental transmission of human subacute spongiform encephalopathy to small rodents. IV. Positive transmission from a typical case of Gerstmann-Straussler-Scheinker's disease. Acta Neuropathol. 64, 85-88 (1984).
137. Baker, H. F., Duchen, L. W., Jacobs, J. M. & Ridley, R. M. Spongiform encephalopathy transmitted experimentally from Creutzfeldt-Jakob and familial Gerstmann-Straussler-Scheinker diseases. Brain 113, 1891-1909 (1990).
138. Bruce, M. E. et al. Strain characterization of natural sheep scrapie and comparison with BSE. J. Gen. Virol. 83, 695-704 (2002).
139. Prusiner, S. B., Cochran, S. P. & Alpers, M. P. Transmission of scrapie in hamsters, J. Infect. Dis. 152, 971-978 (1985).
140. Vilotte, J. L. et al. Markedly increased susceptibility to natural sheep scrapie of transgenic mice expressing ovine PrP. J. Virol. 75, 5977-5984 (2001).
141. Bartz, J. C., Marsh, R. F., McKenzie, D. I. & Aiken, J. M. The host range of chronic wasting disease is altered on passage in ferrets. Virology 251, 297-301 (1998).
142. res in BSE-infected bovine PrP transgenic mice. Arch. Virol. 148, 677-691 (2003).
143. Bons, N. et al. Natural and experimental oral infection of nonhuman primates by bovine spongiform encephalopathy agents. Proc. Natl Acad. Sci. USA 96, 4046-4051 (1999).
144. Lasmezas, C. I. et al. BSE transmission to macaques. Nature 381, 743-744 (1996).
145. Bruce, M. et al. Transmission of bovine spongiform encephalopathy and scrapie to mice: strain variation and the species barrier. Philos. Trans. R. Soc. Lond. B 343, 405-411 (1994).
146. Fraser, H. et al. Transmission of feline spongiform encephalopathy to mice. Vet. Rec. 134, 449 (1994).
147. Bessen, R. A. & Marsh, R. F. Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J. Gen. Virol. 73, 329-334 (1992).
148. Polymenidou, M. et al. Humoral immune response to native eukaryotic prion protein correlates with anti-prion protection. Proc. Natl Acad. Sci. USA 3 August 2004 (doi:10.1073/pnas.0404772101).